XML 54 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
18. Restatement of financial statements (Tables)
9 Months Ended
Sep. 30, 2013
Accounting Changes and Error Corrections [Abstract]  
Schedule of Restatement Impact on Balance Sheet
      Three Months Ended September 30, 2012  
Consolidated Statement of Operations
for Three Months Ended September 30, 2012
    As Previously Reported       Restated       Net Adjustment  
Loss from operations   $ (3,426,250 )   $ (3,426,250 )   $  
                         
Other (income)/expenses                        
Fair value of derivative liabilities in excess of proceeds                  
Adjustments to fair value of derivative securities           (2,022,790 )     (2,022,790 )
Other (income)/expenses     (133,770 )     (133,770 )      
Interest expense     172,057       52,313       (119,744 )
Total other (income)/expenses     38,287       (2,104,247 )     (2,142,534 )
Net loss     (3,464,537 )     (1,322,003 )     2,142,534  
                         
Preferred dividends           119,744       119,744  
Net loss atttributable to common shareholders   $ (3,464,537 )   $ (1,441,747 )   $ 2,022,790  
                         
Basic and diluted loss attributable to common shareholders per share   $ (0.04 )   $ (0.02 )   $ 0.02  
Basic weighted average shares outstanding     89,748,496       89,748,496        
Fully-diluted weighted average shares outstanding     89,748,496       117,915,163       28,166,667  

 

The following table presents the effect of the restatement adjustment on the accompanying consolidated statement of operations for the nine months ended September 30, 2012:

 

 

      Nine Months Ended September 30, 2012  
Consolidated Statement of Operations 
for Nine Months Ended September 30, 2012
    As Previously  Reported       Restated       Net Adjustment  
Loss from operations   $ (8,221,091 )   $ (8,221,091 )   $  
                         
Other (income)/expenses                        
Fair value of derivative liabilities in excess of proceeds                  
Adjustments to fair value of derivative securities           13,845,208       13,845,208  
Other (income)/expenses     626,926       626,926        
Interest expense     469,848       104,431       (365,417 )
Total other (income)/expenses     1,096,774       14,576,565       13,479,791  
Net loss     (9,317,865 )     (22,797,656 )     (13,479,791 )
                         
Preferred dividends           365,417       365,417  
Net loss attributable to common shareholders   $ (9,317,865 )   $ (23,163,073 )   $ (13,845,208 )
                         
Basic and diluted loss attributable to common shareholders per share   $ (0.10 )   $ (0.26 )   $ (0.16 )
Basic weighted average shares outstanding     89,220,298       89,220,298        
Fully-diluted weighted average shares outstanding     89,220,298       117,386,965       28,166,667